Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Chem Biol Drug Des. 2015 Aug 27;87(1):154–158. doi: 10.1111/cbdd.12628

Table 1.

IC50 values (μM) of compounds 1 - 22.

Compound Rhodesain T. brucei Hep G2a
1 0.89 ± 0.10 5.80 ± 1.00 84.71 ± 5.79
2 2.15 ± 0.11 > 20 83.42 ± 9.16
3 1.78 ± 0.20 > 20 92.20 ± 2.07
4 > 20 19.32 ± 0.06 92.67 ± 6.48
5 3.04 ± 0.11 > 20 62.54 ± 1.94
6 2.41 ± 0.11 20.02 ± 0.40 86.31 ± 4.80
7 > 20 2.83 ± 0.26 86.19 ± 9.67
8 1.10 ± 0.10 > 20 97.18 ± 4.67
9 3.38 ± 0.12 18.31 ± 0.52 98.14 ± 6.06
10 > 20 12.93 ± 0.29 80.78 ± 7.91
11 2.36 ± 0.11 > 20 109.00 ± 5.33
12 > 20 > 20 86.97 ± 3.62
13 > 20 9.81 ± 0.81 88.35 ± 6.52
14 0.56 ± 0.10 11.79 ± 1.51 62.09 ± 7.92
15 > 20 > 20 74.01 ± 1.24
16 > 20 > 20 40.20 ± 10.98
17 > 20 > 20 86.49 ± 9.96
18 > 20 > 20 65.53 ± 8.64
19 > 20 14.75 ± 0.15 81.79 ± 10.71
20 > 20 17.06 ± 0.29 88.83 ± 13.35
21 > 20 17.49 ± 1.71 99.72 ± 5.96
22 0.47 ± 0.10 1.93b 5.37c
a

Percent Viability at 20 μM;

b

Macdonald et al. [11],

c

Gold et al. [12].